A novel thromboxane A2 receptor D304N variant which abrogates ligand binding in a patient with a bleeding diathesis

AD Mumford, Ban B Dawood, Martina E Daly, Sherina L Murden, Michael D Williams, Majd B Protty, Jennifer C Spalton, Mark Wheatley, Stuart J Mundell, Steve P Watson

Research output: Contribution to journalArticle (Academic Journal)

50 Citations (Scopus)
Translated title of the contributionA novel thromboxane A2 receptor D304N variant which abrogates ligand binding in a patient with a bleeding diathesis
Original languageEnglish
Pages (from-to)363 - 369
Number of pages7
JournalBlood
Volume115
Issue number2
DOIs
Publication statusPublished - Jan 2010

Cite this

Mumford, AD., Dawood, B. B., Daly, M. E., Murden, S. L., Williams, M. D., Protty, M. B., Spalton, J. C., Wheatley, M., Mundell, S. J., & Watson, S. P. (2010). A novel thromboxane A2 receptor D304N variant which abrogates ligand binding in a patient with a bleeding diathesis. Blood, 115(2), 363 - 369. https://doi.org/10.1182/blood-2009-08-236976